Country: Armenia
Language: English
Source: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
naphazoline (naphazoline hydrochloride)
Alkaloid AD Skopje
S01GA01
naphazoline (naphazoline hydrochloride)
0,3mg/ml
drops eye (solution)
plastic container 10ml
OTC
Registered
2023-04-07
PROCULIN ® 0.3 mg/ ml eye drops, solution _Summary of Product Characteristics _ 1 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT PROCULIN ® 0.3 MG/ML EYE DROPS, SOLUTION 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1 ml of the solution contains 0.3 mg naphazoline hydrochloride. Preservative: benzalkonium chloride 0.06 mg/ ml. For a full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM * eye drops, solution * clear, colourless solution 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS - Conjunctival hyperemia (the preparation enables temporary relief of the minor eye symptoms of itching and redness caused by irritants like dust, smoke, smog, chill, wind, sun, TV rays, swimming, wearing of contact lenses, working with objects close to the eyes such as welding, polishing/grinding); - Allergic conjunctivitis caused by pollen, grass, animal hair etc. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION _Posology in adults_ Usually 1-2 eye drops should be instilled in the affected eye(s) up to 4 times a day. Recommended treatment duration is 3-4 days. _Posology in children and adolescents_ PROCULIN should not be used in children and adolescents due to a lack of data on safety and efficacy (see sections 4.3 and 4.4). _ _ _Posology in elderly patients_ PROCULIN should be used with caution in elderly patients (see section 4.4). Method of administration for ocular use PROCULIN must be used aseptically. To avoid contamination the dropper should not come into contact with any surface and the bottle should be well closed after using. PROCULIN ® 0.3 mg/ ml eye drops, solution _Summary of Product Characteristics _ 2 4.3 CONTRA-INDICATION - Hypersensitivity to naphazoline hydrochloride, or to any of the excipients listed in section 6.1; - Presence of an anatomically narrow angle or narrow-angle glaucoma. The safety of PROCULIN in paediatric patients has not been established, therefore it should not be used in children and adolescents. 4.4 SPECIAL WARNINGS AND SPECIAL PRECAUTIONS FOR USE The drug should b Read the complete document